blood clots semaglutide glp-1 clot meds may lower risk in people with diabetes and Blood Clots: Safety – Semaglutide and Blood Clots: Safety

Not approved by the FDA or TGA.

Nature Medicine , 23 (1), 120127

Observational studies have identified a prevalence of lithium-associated weight gain between 25% (Gomes-da-Costa Reference Gomes-da-Costa, Marx and Corponi2022) and 77% (Gitlin Reference Gitlin2016), with 20% of individuals gaining 10 kg over a 7-year follow-up period (Vestergaard Reference Vestergaard, Poulstrup and Schou1988) and average weight increases of 4.26.3 kg (Gitlin Reference Gitlin2016)

Preoperative micronutrient status in morbidly obese patients before undergoing bariatric surgery: results of a cross-sectional study

Are you ready to experience the benefits of vitamin B12 for yourself